Matibenz 100 Capsule
Marketer
Admac Pharma Ltd
Salt Composition
Imatinib mesylate (100mg)
Overview Matibenz 100 Capsule
Imatinib 100mg capsules are indicated for various cancers. Primary uses include blood cancers (chronic myeloid leukemia and acute lymphoblastic leukemia) and gastrointestinal stromal tumors. Its mechanism involves targeting proteins crucial for cancer cell proliferation and metastasis. Additional applications encompass dermatofibrosarcoma protuberans and aggressive systemic mastocytosis. Administer this medication with food, consistently at the same time daily for optimal efficacy. Treatment duration is determined by individual response and physician guidance. Incorrect usage or overdose may lead to severe adverse reactions. While benefits might not be apparent immediately (weeks or months), discontinue only under medical supervision. Common side effects involve swelling, nausea, vomiting, muscle spasms, musculoskeletal discomfort, diarrhea, skin rash, tiredness, and stomach pain. Report sudden, significant weight increase. Regular blood count and liver function tests may be recommended. Avoid tasks requiring alertness if dizziness or blurred vision occur. Inform your healthcare provider about all concurrent medications due to potential interactions. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception is crucial for both partners throughout treatment.
Primary Ingredients of Matibenz 100 Capsule
No information provided. Please provide the text you wish to be rewritten.
Uses of Matibenz 100 Capsule
Oncological Management
Major Benefits of Matibenz 100 Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Consume Matibenz 100 Capsules with food.
Common Side effects of Matibenz 100 Capsule:
- Edema (swelling)
- Nausea
- Vomiting
- Muscle cramp
- Musculoskeletal (bone, muscle or joint) pain
- Diarrhea
- Rash
- Fatigue
- Abdominal pain
- Bleeding
- Breathing problems
- Cough
- Weight gain
- Dry eye
- Dizziness
- Hemorrhage
How to use Matibenz 100 Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Consume Matibenz 100 Capsules with food.
How Matibenz 100 Capsule works:
Matibenz 100 Capsules target cancerous cells by inhibiting the bcr-abl tyrosine kinase protein enzyme, a key driver of their uncontrolled growth. This anti-cancer drug's mechanism involves suppressing the proliferation of bcr-abl positive cells and triggering programmed cell death (apoptosis), thereby hindering or arresting cancer progression.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Matibenz 100 Capsules may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Matibenz 100 Capsules during pregnancy poses a confirmed risk to the fetus. Therefore, its use is discouraged. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Matibenz 100 Capsule while breastfeeding is likely unsafe. Available human data indicates potential transfer to breast milk, posing a risk to the infant. Nursing mothers should discontinue breastfeeding during Matibenz 100 Capsule use and for a two-week period following cessation.
DrivingUNSAFE
Driving ability may be impaired by side effects associated with Matibenz 100 Capsule.
KidneyCAUTION
Patients with kidney impairment should use Matibenz 100 Capsules cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Matibenz 100 Capsules. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Matibenz 100 Capsule :
Omit any missed Matibenz 100 Capsule dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Matibenz 100 Capsule
| Label | Value |
|---|---|
| Chemical Category | Benzanilide Derivative |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Kinase inhibitors targeting tyrosine |


